A NEW MODEL FOR COLLABORATIVE CLINICAL RESEARCH
WE ARE AN INTERNATIONAL, INNOVATIVE, RESEARCH ORGANIZATION IN CLINICAL ONCOLOGY. OUR GOAL IS TO GENERATE THE MOST INNOVATIVE CLINICAL TRIALS WITH THE MOST PROMISING DRUGS BY FOSTERING GLOBAL COLLABORATIONS BETWEEN EXPERT CLINICAL INVESTIGATORS/KOLs AND PHARMACEUTICAL COMPANIES/BIOTECHS.
WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS
MEDSIR is a company founded by scientific experts in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from study conception to the publication of study results.
MEDSIR favors a new model for collaborative clinical research in oncology development that aims to combine the highest scientific value with the strategic development of novel cancer treatments, with the final goal of benefiting cancer patients worldwide. Our goal is to generate win-win scenarios for all stakeholders involved in independent clinical research.
TOGETHER WE CAN BUILD A BRIGHTER FUTURE
THINK TANK MEETING 2022
We had the pleasure to host a Think Tank Meeting in Barcelona: 5 Key Opinion Leaders (KOLs) in breast cancer field and over 25 breast cancer oncologists from emerging markets of LATAM, Asia and AfME, were invited to a 3-day-dynamic, with the aim of establishing new connections with their colleagues worldwide while learning how to design innovative and strategic trials.
If you’re interested in taking part of the next Think Tank Meeting or would like to sponsor it, don’t hesitate to contact us!
MEDSIR IN NUMBERS
Some examples of MEDSIR ideas matured into strategic clinical trials.
ESMO 2023 - HER2DX PHERGain substudy – DOWNLOAD THE POSTER